Kinase Inhibitors in Drug-design, Drug-discovery, and Drug-delivery
Author:
Affiliation:
1. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara Punjab-144411 India
Abstract
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Reference4 articles.
1. Kumar V.; Kaur N.; Sahu S.; Sharma V.; Kumar D.; Sharma A.; Wadhwa P.; Role of Tyrosine kinases and their inhibitors in cancer therapy: A comprehensive review. Curr Med Chem 2023,30(13),1464-1481
2. Indermun S.; Kumar P.; Govender M.; Choonara Y.E.; Can nanomedicinal approaches provide an edge to the efficacy of tyrosine kinase inhibitors? Curr Med Chem 2023,30(13),1482-1501
3. Al-Huseini I.; Sirasanagandla S.R.; Babu K.S.; Sofin R.G.S.; Das S.; Kinase inhibitors involved in the regulation of autophagy: Molecular concepts and clinical implications. Curr Med Chem 2023,30(13),1502-1528
4. Prasher P.; Sharma M.; Chan Y.; Singh S.K.; Anand K.; Dureja H.; Jha N.K.; Gupta G.; Zacconi F.; Chellappan D.K.; Dua K.; Recent trends in rationally designed molecules as kinase inhibitors. Curr Med Chem 2023,30(13),1529-1567
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3